INMUNE BIO INC. - COMM
5.0500
29-十一月-24 12:45:00
15 分钟延时
股票
+0.1600
+3.27%
今日范围
4.8600 - 5.0500
ISIN
N/A
来源
NASDAQ
-
13 11月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
INmune Bio Inc. Announces Third Quarter 2024 Results and Provides Business Update
31 10月 2024 15:05:51 条件 Nasdaq GlobeNewswire
-
INmune Bio Inc. to Host Webinar on Cognitive Testing Using EMACC and CDR-SB
28 10月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
INmune Bio Inc. Announces Publication in Cell Reports Demonstrating XPro™ Promotes Remyelination
24 10月 2024 14:03:00 条件 Nasdaq GlobeNewswire
-
24 10月 2024 08:30:00 条件 Nasdaq GlobeNewswire
-
INmune Bio Inc. to Participate in the Maxim Healthcare Virtual Summit
11 10月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
INmune Bio Inc. Completes Enrollment for Phase 2 Trial in Early Alzheimer's Disease
30 9月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
INKmune™ Demonstrates Excellent Safety and Increased NK-Cell Activity in First Dosing Cohort
26 9月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
17 9月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
INmune Bio Announces $13.0 Million Registered Direct Offering
13 9月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
INmune Bio Inc. to Present at the Baird 2024 Global Healthcare Conference
03 9月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
INmune Bio Inc. Announces Second Quarter 2024 Results and Provides Business Update
01 8月 2024 15:05:39 条件 Nasdaq GlobeNewswire
-
29 7月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
25 7月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
23 7月 2024 07:45:00 条件 Nasdaq GlobeNewswire
-
INmune Bio, Inc. Completes Blinded Interim Analysis of Phase II Alzheimer’s Disease Trial
27 6月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
INmune Bio Inc. to Join Russell 3000® Index
30 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business Update
09 5月 2024 15:05:36 条件 Nasdaq GlobeNewswire
-
07 5月 2024 07:00:01 条件 Nasdaq GlobeNewswire
-
30 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >